Huaren Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	185.49	138.97	163.81	232.04	221.71	417.15
Cash & Short-Term Investments	185.49	138.97	163.81	232.04	221.71	417.15
Cash Growth	1.93%	-15.16%	-29.40%	4.66%	-46.85%	82.42%
Accounts Receivable	585.72	555.21	628.45	806.11	739.22	887.34
Other Receivables	28.78	20.99	34.71	1,364	1,430	1,419
Receivables	614.5	576.2	663.15	2,170	2,169	2,306
Inventory	245.72	241.51	318.24	334.63	266.85	275.47
Other Current Assets	60.36	37.19	39.77	54.51	71.8	109.27
Total Current Assets	1,106	993.88	1,185	2,791	2,730	3,108
Property, Plant & Equipment	1,070	1,094	1,076	1,116	1,139	1,219
Long-Term Investments	15.98	15.98	16.58	16.58	16.58	16.58
Goodwill	207.89	207.89	732.61	820.04	826.29	826.64
Other Intangible Assets	278.51	284.05	301.7	318.53	331.77	366.16
Long-Term Deferred Tax Assets	70.9	70.99	57.19	42.03	56.87	46.4
Long-Term Deferred Charges	8.92	9.72	18.13	29.1	27.15	22.6
Other Long-Term Assets	29.39	25.89	40.88	32.13	35.72	36.58
Total Assets	2,788	2,702	3,428	5,166	5,163	5,642
Accounts Payable	179.74	199.9	147.35	142.32	122.75	127.08
Accrued Expenses	15.08	15.51	185.72	192.22	206.03	183.32
Short-Term Debt	437.2	330.42	424.41	624.83	1,218	1,579
Current Portion of Long-Term Debt	389.29	633.86	389.02	101.8	98.96	29.96
Current Portion of Leases	-	-	-	0.59	1.08	0.86
Current Income Taxes Payable	30.63	21.21	9.83	15.93	32.78	28.54
Current Unearned Revenue	29.5	33.71	32.46	55.55	32	28.17
Other Current Liabilities	267.25	239.92	357.84	383.01	317.41	613.99
Total Current Liabilities	1,349	1,475	1,547	1,516	2,029	2,591
Long-Term Debt	464.13	270.22	464.08	836.42	352.74	230.36
Long-Term Leases	1.1	0.79	-	0.16	0.41	0.26
Long-Term Unearned Revenue	8.29	7.05	0.13	0.18	0.72	2.77
Long-Term Deferred Tax Liabilities	39.59	40.36	43.35	46.72	50.93	55.87
Other Long-Term Liabilities	-	-	-	-	128.86	318.11
Total Liabilities	1,862	1,793	2,054	2,400	2,563	3,198
Common Stock	1,182	1,182	1,182	1,182	1,182	1,182
Additional Paid-In Capital	528.04	528.04	528.04	528.04	528.04	528.04
Retained Earnings	-856.41	-872.37	-409.47	983.83	820.59	661.09
Total Common Equity	853.84	837.89	1,301	2,694	2,531	2,371
Minority Interest	72.02	71.17	73.14	71.86	68.88	72.09
Shareholders' Equity	925.86	909.06	1,374	2,766	2,600	2,443
Total Liabilities & Equity	2,788	2,702	3,428	5,166	5,163	5,642
Total Debt	1,292	1,235	1,278	1,564	1,672	1,840
Net Cash (Debt)	-1,106	-1,096	-1,114	-1,332	-1,450	-1,423
Net Cash Per Share	-0.94	-0.93	-0.94	-1.13	-1.23	-1.20
Filing Date Shares Outstanding	1,182	1,184	1,182	1,182	1,182	1,182
Total Common Shares Outstanding	1,182	1,184	1,182	1,182	1,182	1,182
Working Capital	-242.62	-480.66	-361.65	1,275	700.13	517.09
Book Value Per Share	0.72	0.71	1.10	2.28	2.14	2.01
Tangible Book Value	367.44	345.94	266.47	1,556	1,373	1,179
Tangible Book Value Per Share	0.31	0.29	0.23	1.32	1.16	1.00
Buildings	-	-	1,098	1,096	1,089	1,082
Machinery	-	-	1,378	1,347	1,385	1,401
Construction In Progress	-	-	61.9	41.95	23.36	7.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.